Correlation Between NRx Pharmaceuticals and Biofrontera Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Biofrontera Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Biofrontera Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Biofrontera Warrants, you can compare the effects of market volatilities on NRx Pharmaceuticals and Biofrontera Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Biofrontera Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Biofrontera Warrants.

Diversification Opportunities for NRx Pharmaceuticals and Biofrontera Warrants

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between NRx and Biofrontera is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Biofrontera Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera Warrants and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Biofrontera Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera Warrants has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Biofrontera Warrants go up and down completely randomly.

Pair Corralation between NRx Pharmaceuticals and Biofrontera Warrants

Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 2.05 times less return on investment than Biofrontera Warrants. But when comparing it to its historical volatility, NRx Pharmaceuticals is 2.09 times less risky than Biofrontera Warrants. It trades about 0.22 of its potential returns per unit of risk. Biofrontera Warrants is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  7.62  in Biofrontera Warrants on September 25, 2024 and sell it today you would earn a total of  4.38  from holding Biofrontera Warrants or generate 57.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy94.74%
ValuesDaily Returns

NRx Pharmaceuticals  vs.  Biofrontera Warrants

 Performance 
       Timeline  
NRx Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NRx Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, NRx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Biofrontera Warrants 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

NRx Pharmaceuticals and Biofrontera Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NRx Pharmaceuticals and Biofrontera Warrants

The main advantage of trading using opposite NRx Pharmaceuticals and Biofrontera Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Biofrontera Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera Warrants will offset losses from the drop in Biofrontera Warrants' long position.
The idea behind NRx Pharmaceuticals and Biofrontera Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.